Although PSA has been the go-to test for screening and diagnosis since 1986 [45], its use is becoming increasingly controversial, as it has been demonstrated to lead to overdiagnosis and overtreatment of PCa that is clinically insignificant [46,47]. Here, KLK3 is linked to posterior cortical atrophy.